Effectiveness of a penicillin allergy delabeling program—real-world data from Croatia
Main Article Content
Keywords
penicillin allergy, allergy delabeling, drug provocation test, real-world data, specific IgE
Abstract
Penicillin allergy is the most commonly reported drug allergy, often leading to unnecessary avoidance of beta-lactam antibiotics, increased use of alternative broad-spectrum antibiotics, and higher healthcare costs. However, studies indicate that over 90% of penicillin allergy labels are erroneous. This study presents real-world data from a penicillin allergy delabeling program conducted at the Special Hospital for Pulmonary Diseases in Zagreb, Croatia. A total of 132 adult patients with a reported beta-lactam allergy were evaluated with a stepwise diagnostic protocol, including medical history review, skin tests, specific IgE, and drug provocation tests. Five patients were delabeled directly, while 127 underwent diagnostic testing. Among 121 participants who completed the protocol, penicillin allergy was confirmed in 13 (10.74%) patients, and the label was retained in an additional 3 patients because of high-risk history, resulting in an overall confirmed allergy rate of 13.2%. The negative predictive values for STs were 99.07% and 94.39% for immediate and delayed reactions, respectively, while the NPV of sIgE for immediate reactions was 100%. No severe reactions occurred during the diagnostic process. Hundred and five out of one hundred and thirty two (79.5%) patients were safely delabeled. These findings confirm the safety and effectiveness of PAD programs in outpatient settings and highlight the potential for improving antibiotic stewardship by reducing unnecessary beta-lactam avoidance.
References
2 Castells M, Khan DA, Phillips EJ. Penicillin Allergy. Longo DL, editor. N. Engl. J. Med. 2019 Dec 12;381(24):2338–51. 10.1056/NEJMra1807761
3 Iuliano S, Senn L, Moi L, Muller YD, Ribi C, Buss G, et al. Management of beta-lactam antibiotics allergy: a real-life study. Front. Allergy. 2022 Apr 8;3:853587. 10.3389/falgy.2022.853587
4 Brockow K, Wurpts G, Trautmann A. Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions. Allergol Sel. 2022 Jan 1;6(01):33–41. 10.5414/ALX02310E
5 Stone CA, Trubiano J, Coleman DT, Rukasin CRF, Phillips EJ. The challenge of de-labeling penicillin allergy. Allergy. 2020 Feb;75(2):273–88. 10.1111/all.13848
6 Lee R. Penicillin allergy delabeling can decrease antibiotic resistance, reduce costs, and optimize patient outcomes. Fed. Pract. [Internet]. 2020 Oct 10 [cited 2025 Jan 5];(Vol 37 No 10). Available from: https://www.mdedge.com/fedprac/article/229631/hospital-medicine/penicillin-allergy-delabeling-can-decrease-antibiotic
7 Fransson S, Boel JB, Mosbech HF, Garvey LH. Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care. World Allergy Organ. J. 2024 Sep 17(9):100958. 10.1016/j.waojou.2024.100958
8 Macy E and Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J. Allergy Clin. Immunol. 2014 Mar 133(3):790–6. 10.1016/j.jaci.2013.09.021
9 Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018 Jun 27;k2400. 10.1136/bmj.k2400
10 Doña I, Labella M, Bogas G, Sáenz De Santa María R, Salas M, Ariza A, et al. Antibiotic allergy de-labeling: a pathway against antibiotic resistance. Antibiotics. 2022 Aug 3;11(8):1055. 10.3390/antibiotics11081055
11 smpc_dap_penicilina_en.pdf [Internet]. [cited 2025 Jan 4]. Available from: https://www.diater.com/media/attachments/2023/08/03/smpc_dap_penicilina_en.pdf
12 Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs—an ENDA / EAACI Drug Allergy Interest Group position paper. Allergy. 2013 Jun;68(6):702–12. 10.1111/all.12142
13 Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput. Biol. Med. 2000 May 30(3):127–34. 10.1016/S0010-4825(00)00006-8
14 Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A, et al. Development and validation of a penicillin allergy clinical decision rule. JAMA Intern. Med. 2020 May 1;180(5):745. 10.1001/jamainternmed.2020.0403
15 Su C, Belmont A, Liao J, Kuster JK, Trubiano JA, Kwah JH. Evaluating the PEN-FAST clinical decision-making tool to enhance penicillin allergy delabeling. JAMA Intern. Med. 2023 Aug 1;183(8):883. 10.1001/jamainternmed.2023.1572
16 Sabato V, Gaeta F, Valluzzi RL, Van Gasse A, Ebo DG, Romano A. Urticaria: the 1-1-1 criterion for optimized risk stratification in β-lactam allergy delabeling. J. Allergy Clin. Immunol. Pract. 2021 Oct 9(10):3697–704. 10.1016/j.jaip.2021.05.037
17 Alnæs MB, Oppegaard O, Kittang BR, Lygre SHL, Langeland AB, Skodvin B, et al. A new pathway for penicillin delabeling in Norway. World Allergy Organ. J. 2023 Nov 16(11):100829. 10.1016/j.waojou.2023.100829
18 Sousa-Pinto B, Tarrio I, Blumenthal KG, Araújo L, Azevedo LF, Delgado L, et al. Accuracy of penicillin allergy diagnostic tests: a systematic review and meta-analysis. J Allergy Clin. Immunol. 2021 Jan 147(1):296–308. 10.1016/j.jaci.2020.04.058
19 Doña I, Guidolin L, Bogas G, Olivieri E, Labella M, Schiappoli M, et al. Resensitization in suspected penicillin allergy. Allergy. 2023 Jan;78(1):214–24. 10.1111/all.15508
20 Solensky R and Khan DA. Evaluation of antibiotic allergy: the role of skin tests and drug challenges. Curr. Allergy Asthma. Rep. 2014 Sep 14(9):459. 10.1007/s11882-014-0459-z
21 Rosenfield L, Kalicinsky C, Warrington R. A retrospective comparison of false negative skin test rates in penicillin allergy, using pencilloyl-poly-lysine and minor determinants or Penicillin G, followed by open challenge. Allergy Asthma Clin. Immunol. 2015 Dec 11(1):34. 10.1186/s13223-015-0098-5
22 Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet J, et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams—an EAACI position paper. Allergy. 2020 Jun;75(6):1300–15. 10.1111/all.14122
23 Atanaskovic-Markovic M, Gaeta F, Medjo B, Gavrovic-Jankulovic M, Cirkovic Velickovic T, Tmusic V, et al. Nonimmediate hypersensitivity reactions to beta-lactam antibiotics in children—our 10-year experience in allergy workup. Pediatr. Allergy Immunol. 2016 Aug 27(5):533–8. 10.1111/pai.12565
24 Wurpts G, Aberer W, Dickel H, Brehler R, Jakob T, Kreft B, et al. Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics. Allergol Sel. 2020 Jan 1;4(01):11–43. 10.5414/ALX02104E
25 Lendal V, Fransson S, Mosbech H, Boel JB, Kahlhofen N, Blom LH, et al. Clinical relevance of specific IgE in penicillin allergy investigation. Int. Arch. Allergy Immunol. 2024 Oct 25;1–8. 10.1159/000541243
26 Blanca M, Mayorga C, Torres MJ, Reche M, Moya C, Rodriguez JL, et al. Clinical evaluation of pharmacia CAP systemTM RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy. 2001 Sep;56(9):862–70. 10.1034/j.1398-9995.2001.00995.x
27 Petrac L, Gvozdanovic K, Perkovic V, Petek Zugaj N, Ljubicic N. Antibiotics prescribing pattern and quality of prescribing in Croatian dental practices-5-year national study. Antibiotics. 2024 Apr 9;13(4):34. 10.3390/antibiotics13040345